Abstract
We analyzed the COVID-19 infection rate among undergraduate students at 9 colleges and Universities in the greater Boston area and 4 comparison schools elsewhere, from Fall 2020. We assessed whether the cumulative rate of infection is dependent on the mode of instruction (in-person, hybrid, or remote), on the number and density of dorm-resident undergraduates, and/or on COVID-19 testing cadence. We limited our analysis to institutions that have implemented at least weekly PCR testing of dormitory-resident undergraduates. Our primary conclusions are that (i) the fraction of students that succumbed to a COVID-19 infection up through Nov 22, 2020 shows no correlation with either the total number of students on campus, or the fractional occupancy of dormitories, (ii) remote instruction vs. hybrid instruction has no significant measurable impact on cumulative infection rate, and (iii) there is evidence that testing 2 or 3 times per week is correlated with lower infection rates than weekly testing. These data are consistent with a hypothesis of students predominantly acquiring infection off-campus, with little community transmission within dormitory housing. This implies good student compliance with face mask and social distancing protocols.
Significance Statement We review the incidence of COVID-19 infection among under-graduate students for selected colleges and universities that conducted at least weekly COVID-19 testing during the Fall of 2020. We analyzed the infection-rate dependence on number of students on campus, dormitory residential density, instructional methodology (remote vs. hybrid), and testing cadence. This compilation of outcomes can help inform policy decisions for congregate settings.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB was needed
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
T.S.T. located and wrangled the input data, C.W.S. and M.S. performed the analysis. The authors declare that they have no competing interests.
Data Availability
Data was downloaded from the cubically available dashboard for universities. Code available upon request.
